Bifidumbacterin, tablets 1 dose, 5 doses - instructions for use, dose, side effects, contraindications

Tablets of white with a gray tinge or different shades of beige, allowed "marbling" color, have a round shape with flat or slightly convex smooth surfaces. The drug has a specific smell and taste.

Pharmacotherapeutic group:Eubiotic

ATX: & nbsp

A.07.F.A Antidiarrhoeal preparations of biological origin regulating the balance of intestinal microflora

Pharmacodynamics:

Bifidumbacterin tablet is a lyophilized microbial mass of living bacteria of an antagonistically active strain Bifidobacterium bifidum 791, compressed into tablets.

The therapeutic effect of bifidumbacterin determines the living bifidobacteria contained in it, which have antagonistic activity against a wide range of pathogenic and opportunistic microorganisms and thereby normalize the intestinal microflora. The high quantitative level of bifidoflora and its predominance in microbiocenosis, achieved with the use of bifidumbacterin, normalizes the activity of the gastrointestinal tract, improves metabolic processes,prevents the formation of protracted forms of intestinal diseases, increases the nonspecific resistance of the body.

Purpose: treatment and prevention of dysbacteriosis of various etiologies in children from 3 years of age and adults.

Indications:

- Prolonged intestinal dysfunction of unknown etiology;

- complex treatment of children suffering from pneumonia, sepsis and other septic-purulent diseases, preventing or stopping their bowel function disorders and preventing the development of ulcerative-necrotic enterocolitis;

- acute intestinal infections (in the complex treatment of acute dysentery, salmonella, escherichiosis, viral diarrhea, etc.);

- long intestinal dysfunctions of staphylococcal etiology, as well as treatment of convalescents after acute intestinal infections with continuing intestinal dysfunction;

- acute and chronic inflammatory diseases of the large and small intestine (colitis, enterocolitis) that occur against the background of microflora disorders with deficiency or lack of bifidoflora in older children and adults;

- intestinal dysfunction in the presence of dysbacteriosis of the intestine, which arose as a result of prolonged antibacterial, hormonal, radiation and other therapy,under stressful situations and staying in extreme conditions, as well as for the prevention of dysbiotic disorders.

Contraindications:

Not installed.

Pregnancy and lactation:

Bifidobacteria are representatives of normal human microflora. Therefore, drugs made on their basis, can be used in pregnancy and lactation.

Dosing and Administration:

Bifidumbacterin tablets are used for 20-30 minutes before meals through the mouth, swallowing, washing with boiled water at room temperature, or by dissolving.

Use in children:

With intestinal diseases prescribe 5 doses 2 times a day.

With sepsis, pneumonia and other purulent-infectious diseases prescribe 5 doses 3 times a day in combination with drug treatment of the underlying disease. If a group of children develops disorders of the gastrointestinal tract and the threat of developing a ulcerative-necrotic enterocolitis, the dose of bifidumbacterin is increased to 10 doses 2 times a day.

Application in adults:

In acute and chronic inflammatory diseases of the small and large intestine, enterocolitis and colitis appoint: 5 doses 2-3 times a day.

With intestinal diseases duration of treatment with bifidumbacterin is determined by the severity of clinical manifestations and is 2-4 weeks, and in some cases up to 3 months.

For preventive purposes prescribe 5 doses 2 times a day for 1-2 weeks.

If necessary, the course of treatment with bifidumbacterin can be repeated.

Side effects:

Not identified.

Interaction:

The use of tablets can be combined with the simultaneous carrying out of antibacterial, antiviral and immunomodulatory therapy.

Special instructions:

The drug does not affect the performance of activities requiring special attention and quick reactions (management of vehicles, machinery, etc.).

Form release / dosage:Pills, 1 dose and 5 doses.

Packaging:

For 20, 30, 60 tablets in a can of propylene with a cap made of propylene with control of the first opening.

1 bank in a pack of cardboard with instructions for use.

Storage conditions:

The preparation is stored in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 10 ° C.

Keep out of the reach of children.

Transport conditions: the preparation is transported in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 10 ° C.

The drug is not suitable for use:

- expired;

- without marking;

- the integrity of the packaging is broken;

- with deformed tablets in the jar.

Shelf life:

1 year.

Terms of leave from pharmacies:Without recipe

Registration number:P N000412 / 01

Date of registration:21.02.2011

Expiration Date:Unlimited

The owner of the registration certificate:VITAFARMA FIRM, CJSC VITAFARMA FIRM, CJSC Russia

Manufacturer: & nbsp

VITAFARMA FIRM, CJSC Russia

Representation: & nbspVITAFARMA FIRM, CJSCVITAFARMA FIRM, CJSC

Information update date: & nbsp16.02.2017

Illustrated instructions

Instructions

Bifidumbacterin, tablets 1 dose, 5 doses (Bifidumbacterin)